GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (BUE:LLY) » Definitions » Shiller PE Ratio

Eli Lilly and Co (BUE:LLY) Shiller PE Ratio : 173.80 (As of Jun. 03, 2024)


View and export this data going back to . Start your Free Trial

What is Eli Lilly and Co Shiller PE Ratio?

As of today (2024-06-03), Eli Lilly and Co's current share price is ARS17837.50. Eli Lilly and Co's E10 for the quarter that ended in Mar. 2024 was ARS102.63. Eli Lilly and Co's Shiller PE Ratio for today is 173.80.

The historical rank and industry rank for Eli Lilly and Co's Shiller PE Ratio or its related term are showing as below:

BUE:LLY' s Shiller PE Ratio Range Over the Past 10 Years
Min: 16.02   Med: 31.69   Max: 154.88
Current: 154.7

During the past years, Eli Lilly and Co's highest Shiller PE Ratio was 154.88. The lowest was 16.02. And the median was 31.69.

BUE:LLY's Shiller PE Ratio is ranked worse than
96.09% of 537 companies
in the Drug Manufacturers industry
Industry Median: 24.1 vs BUE:LLY: 154.70

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Eli Lilly and Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ARS8,357.600. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ARS102.63 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Eli Lilly and Co Shiller PE Ratio Historical Data

The historical data trend for Eli Lilly and Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Shiller PE Ratio Chart

Eli Lilly and Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.70 42.58 63.05 74.95 115.37

Eli Lilly and Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.68 93.19 109.07 115.37 146.70

Competitive Comparison of Eli Lilly and Co's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Shiller PE Ratio falls into.



Eli Lilly and Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Eli Lilly and Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=17837.50/102.63
=173.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Eli Lilly and Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=8357.6/131.7762*131.7762
=8,357.600

Current CPI (Mar. 2024) = 131.7762.

Eli Lilly and Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 22.100 100.560 28.961
201409 15.828 100.428 20.769
201412 13.197 99.070 17.554
201503 17.639 99.621 23.332
201506 20.354 100.684 26.640
201509 28.207 100.392 37.025
201512 22.409 99.792 29.591
201603 23.951 100.470 31.414
201606 39.702 101.688 51.449
201609 43.557 101.861 56.349
201612 44.455 101.863 57.510
201703 -6.167 102.862 -7.901
201706 62.654 103.349 79.888
201709 37.150 104.136 47.011
201712 -120.680 104.011 -152.895
201803 93.491 105.290 117.010
201806 -24.940 106.317 -30.912
201809 164.860 106.507 203.974
201812 160.532 105.998 199.573
201903 673.912 107.251 828.020
201906 257.351 108.070 313.805
201909 306.474 108.329 372.807
201912 373.477 108.420 453.932
202003 397.244 108.902 480.685
202006 424.452 108.767 514.242
202009 394.957 109.815 473.942
202012 720.330 109.897 863.741
202103 536.877 111.754 633.063
202106 579.748 114.631 666.458
202109 477.166 115.734 543.306
202112 731.163 117.630 819.096
202203 901.925 121.301 979.813
202206 505.386 125.017 532.711
202209 894.838 125.227 941.641
202212 1,367.550 125.222 1,439.131
202303 1,177.398 127.348 1,218.341
202306 1,872.000 128.729 1,916.317
202309 -83.988 129.860 -85.228
202312 3,330.369 129.419 3,391.017
202403 8,357.600 131.776 8,357.600

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Eli Lilly and Co  (BUE:LLY) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Eli Lilly and Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eli Lilly and Co (BUE:LLY) Business Description

Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.